Ignite Creation Date:
2024-05-05 @ 11:20 PM
Last Modification Date:
2024-10-26 @ 10:32 AM
Study NCT ID:
NCT01308177
Status:
UNKNOWN
Last Update Posted:
2011-03-03
First Post:
2011-03-02
Brief Title:
Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Study Overview
Official Title:
Efficacy of an Ecabet Sodium and Proton Pump Inhibitor PPI Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection A Prospective Randomized Controlled Trial
Status:
UNKNOWN
Status Verified Date:
2011-03
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Endoscopic submucosal dissection ESD is widely indicated to treat gastric adenomas and early gastric cancer EGCESD is able to obtain en bloc resection of larger specimens However ESD has more frequent complications delayed bleeding ulcer healing ulcer pain and etc due to a more complex procedure To prevent delayed bleeding to induce rapid ulcer healing and to control the ulcer pain acid-suppressing agents PPI H2RA are generally administered although PPIs are widely indicated as first-line drugs for peptic ulcers PPI drugs are not fully superior to H2RAs or other combination drugs for treatment of iatrogenic ulcer healing and delayed bleeding
Ecabet sodium ESis a widely used mucoprotective agent for the treatment of gastric ulcers Recently one study showed the additional benefits of using ES in combination with the PPI after ESD however this study did not show the difference of delayed bleeding and the benefit of ulcer pain control thus our study prospectively evaluated the difference of delayed bleeding and the benefit of ulcer pain control after ESD
Ecabet sodium ESis a widely used mucoprotective agent for the treatment of gastric ulcers Recently one study showed the additional benefits of using ES in combination with the PPI after ESD however this study did not show the difference of delayed bleeding and the benefit of ulcer pain control thus our study prospectively evaluated the difference of delayed bleeding and the benefit of ulcer pain control after ESD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None